Just like humans, dogs also get cataracts when opacity on the lens of the eye develops. In its early stages cataract may not cause any visual problems, however as it matures can cause blurry or cloudy vision and eventually may result in total loss of sight. When this occurs, the usual veterinary treatment is the same as with humans. Corrective eye surgery is recommended in which the defective lens is removed and replaced by an artificial lens, IOL. Intraocular lens is a clear plastic lens that effectively allows light to enter into the retina of the eye thus aiding in vision.
Cataracts are one of the most common eye disorders affecting dogs. Often they are inherited and can develop over a number of years affecting one or both eyes. Dogs develop senile cataracts usually when approaching the age of 8 years and above. Canine cataracts also develop as a result of diseases such as diabetes mellitus. In the diagnosis of canine cataracts, it’s important to differentiate this particular disease from nuclear sclerosis, another eye disease occurring in geriatric dogs. Nuclear Sclerosis is also characterized by a grayish appearance of the lens caused by the hardening of the lens itself and does not pose the same risk to vision that a cataract is likely to cause.
Surgical cataract treatment is not only expensive but also poses risks in the form of post surgery complications. For those dog owners who don’t want their pets to go under the knife, an alternative is now available in the form of a new cataract eye drop. Can-CTM (N-Acetylcarnosine) eye drops are now being recommended by dog owners and veterinarians alike for the non-invasive treatment of canine cataracts.
Can-CTM is the result of an extensive study by a group of medical researchers headed by Dr. Mark Babizhayev MA PhD, founder of Innovative Vision Products. A Russian clinical study was done on thirty dogs. Each one received a daily dose of Can-CTM 1% N-acetylcarnosine eye drop solution twice a day. Results showed that 96% of the canine eyes showed notable improvement within weeks of the treatment. Dogs suffering either from immature or ripe cataracts showed significant visual improvements. Cataract reversal started from the periphery of the cataract which was then followed by a gradual increased transparency over the entire lens. These impressive results were conducted and done with no negative side effects noted.
The active ingredient in Can-CTM eye drops that reverses dog cataracts is N-acetylcarnosine, a di-peptide, from the parent compound carnosine. This molecule has antioxidant and anti-glycate properties that combat age-related diseases such as cataracts. The carrier, N-acetylcarnosine or more specifically, the N-acetyl part of the compound helps in letting the relatively lipid insoluble, carnosine to be absorbed by the lipid membrane of the cornea and lens. Once absorbed, it naturally breaks down to its basic form, L-carnosine, where the healing benefits to the eye begin to take effect.
Effectiveness in the treatment of canine cataract has been reported by all customers who have used Can-CTM eye drops for their dogs. The level of improvement though depends on the stage and maturity of the cataract. Oftentimes, complete cataract reversal can be achieved but with very mature cataracts and those that are injury induced or those that resulted from steroid medication the good results are not likely to be as pronounced.
It is important as a pet owner to know the alternatives available enabling you to make an informed decision about the treatment options available for your pet.
This article is free to republish provided the authors resource box remains intact.
Leslie Burke has a vast knowledge and experience with Can-C™ N-Acetylcarnosine – N-Acetyl-Carnosine eye drops and the effects on canine cataracts.